DE60215917D1 - Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen - Google Patents

Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen

Info

Publication number
DE60215917D1
DE60215917D1 DE60215917T DE60215917T DE60215917D1 DE 60215917 D1 DE60215917 D1 DE 60215917D1 DE 60215917 T DE60215917 T DE 60215917T DE 60215917 T DE60215917 T DE 60215917T DE 60215917 D1 DE60215917 D1 DE 60215917D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
alkoxy
treatment
tripepide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60215917T
Other languages
English (en)
Other versions
DE60215917T2 (de
Inventor
Jean Rapin
Klaus Witzmann
Jean-Marie Grumel
Jacques Gonella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NeuroTell AG
Original Assignee
NeuroTell AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NeuroTell AG filed Critical NeuroTell AG
Publication of DE60215917D1 publication Critical patent/DE60215917D1/de
Application granted granted Critical
Publication of DE60215917T2 publication Critical patent/DE60215917T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60215917T 2001-02-05 2002-02-05 Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen Expired - Lifetime DE60215917T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10105041A DE10105041A1 (de) 2001-02-05 2001-02-05 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105041 2001-02-05
PCT/EP2002/001180 WO2002062828A2 (en) 2001-02-05 2002-02-05 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases

Publications (2)

Publication Number Publication Date
DE60215917D1 true DE60215917D1 (de) 2006-12-21
DE60215917T2 DE60215917T2 (de) 2007-09-13

Family

ID=7672834

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10105041A Withdrawn DE10105041A1 (de) 2001-02-05 2001-02-05 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE60215917T Expired - Lifetime DE60215917T2 (de) 2001-02-05 2002-02-05 Tripepide und tripepdid-derivte zur behandlung von neurodegenerativen erkrankungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10105041A Withdrawn DE10105041A1 (de) 2001-02-05 2001-02-05 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten

Country Status (11)

Country Link
US (1) US7129213B2 (de)
EP (1) EP1359934B1 (de)
JP (1) JP4169597B2 (de)
AT (1) ATE344673T1 (de)
AU (1) AU2002231771A1 (de)
CY (1) CY1107990T1 (de)
DE (2) DE10105041A1 (de)
DK (1) DK1359934T3 (de)
ES (1) ES2275849T3 (de)
PT (1) PT1359934E (de)
WO (1) WO2002062828A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
AU2003249920A1 (en) * 2002-07-02 2004-01-23 Novartis Ag Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
US20100166859A1 (en) * 2006-01-16 2010-07-01 Luppo Edens Novel nutraceutical compositions and use thereof
US7838971B2 (en) * 2006-07-11 2010-11-23 Atmel Corporation Method to provide substrate-ground coupling for semiconductor integrated circuit dice constructed from SOI and related materials in stacked-die packages
JP2013500986A (ja) 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
JP6344796B2 (ja) * 2014-09-30 2018-06-20 森永乳業株式会社 高齢者用アルツハイマー型認知症改善剤
JP6589011B2 (ja) * 2018-05-17 2019-10-09 森永乳業株式会社 脳機能障害改善用経口組成物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323301C (en) 1987-06-05 1993-10-19 Alan I. Faden Thyrotropin-releasing hormone analogs in cns injury
FR2622581B1 (fr) * 1987-11-03 1990-02-16 Inorgan Sa Rech Develop Pharm Nouveaux derives de l-proline, leur preparation et leurs applications biologiques
DE69124274T2 (de) * 1990-02-27 1997-08-14 Agency Ind Science Techn Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
DE4007869A1 (de) 1990-03-13 1991-09-19 Merck Patent Gmbh Aminosaeurederivate
JPH045240A (ja) * 1990-04-20 1992-01-09 Taisho Pharmaceut Co Ltd 抗痴呆剤
US5091391A (en) * 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
CA2098609A1 (en) * 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
WO1992013549A1 (en) * 1991-02-07 1992-08-20 Research Corporation Technologies, Inc. Inhibition of cell proliferation by hydrophobic peptides
US6235929B1 (en) * 1991-12-27 2001-05-22 Georgia Tech Research Corporation Tripeptide α-ketoamides
CZ134296A3 (en) * 1993-11-09 1996-12-11 Merck & Co Inc Piperidine, pyrrolidine and hexahydro-1h-azepine derivatives, process of their preparation and pharmaceutical compositions containing thereof
JP2800877B2 (ja) * 1993-12-28 1998-09-21 伊藤ハム株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
CA2180844A1 (en) * 1994-01-13 1995-07-20 W. Clark Still Synthetic receptors, libraries and uses thereof
US5716929A (en) 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5834029A (en) 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
JPH0940577A (ja) * 1995-05-24 1997-02-10 Mitsui Toatsu Chem Inc トリペプチド、ジペプチドを含有する医薬組成物
CA2224721A1 (en) 1995-06-13 1996-12-27 Matthew S. Miller Calpain inhibitors for the treatment of neurodegenerative diseases
ES2238682T3 (es) * 1995-06-23 2005-09-01 Mg Pharma Inc. Peptido que inhibe la elevacion del nivel de trigliceridos en sangre e inhibidor de la elevacion del nivel de trigliceridos en sangre que contiene dicho peptido como ingrediente activo.
JPH09169797A (ja) * 1995-12-22 1997-06-30 Mitsui Toatsu Chem Inc プロテアーゼアクティベーター活性を有するペプチド
US5840838A (en) * 1996-02-29 1998-11-24 University Of Kentucky Research Foundation Process for enhancing the activity of amyloid β peptides
JP2805194B2 (ja) * 1996-03-22 1998-09-30 阪急共栄物産株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
WO1998014202A1 (en) * 1996-10-04 1998-04-09 Auckland Uniservices Limited Regulation of neural enzymes
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
JPH11124398A (ja) * 1997-10-22 1999-05-11 Japan Energy Corp Ｃ型肝炎ウイルス由来の抗原ペプチドとそれを用いる抗体検査薬
JP3108675B2 (ja) * 1998-03-17 2000-11-13 阪急共栄物産株式会社 脂質代謝改善剤
US6080848A (en) * 1998-05-01 2000-06-27 Incyte Pharmaceuticals, Inc. Human brain associated protein
WO2001028578A2 (en) 1999-10-22 2001-04-26 Wrair A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
WO2001068114A1 (en) * 2000-03-10 2001-09-20 Monsanto Company Novel peptides with anti-hypertensive activity
DE10105041A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
US6846641B2 (en) * 2002-04-23 2005-01-25 Agy Therapeutics, Inc. In vitro ischemia model

Also Published As

Publication number Publication date
JP4169597B2 (ja) 2008-10-22
DE10105041A1 (de) 2002-08-14
DK1359934T3 (da) 2007-03-12
CY1107990T1 (el) 2013-09-04
US7129213B2 (en) 2006-10-31
EP1359934B1 (de) 2006-11-08
WO2002062828A2 (en) 2002-08-15
US20050101538A1 (en) 2005-05-12
DE60215917T2 (de) 2007-09-13
PT1359934E (pt) 2007-01-31
WO2002062828A3 (en) 2002-10-10
ATE344673T1 (de) 2006-11-15
ES2275849T3 (es) 2007-06-16
EP1359934A2 (de) 2003-11-12
AU2002231771A1 (en) 2002-08-19
JP2004526704A (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
CY1107990T1 (el) Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
NZ230916A (en) Peptidase inhibitors and pharmaceutical compositions thereof
ATE254630T1 (de) Cyclosporine
ATE328901T1 (de) Verfahren für die behandlung der multiplen sklerose mittels peptidanalogen des menschlichen basischen myelinproteins
RO115355B1 (ro) Derivati de aminoacizi
ES2187958T3 (es) Antagonistas de gnrh.
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
NO980195L (no) Cyklosporinderivater med anti-HIV-effekt
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
IE51259B1 (en) Angiotensin converting enzyme inhibitors
NO20031671L (no) Dioksolananaloger for forbedret intercellulaer avlevering
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
CA2248630A1 (en) Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
ATE285244T1 (de) Tripeptide und deren derivate zur behandlung von postläsionalen krankheiten des nervensystems
MXPA02004505A (es) Peptidos mimeticos para epitope de apolipoproteinab-100 concatamero y peptidos modificados del mismo, y la composicion de vacuna que comprende los mismos.
ATE310529T1 (de) Tripeptidderivate zur behandlung von postläsionalen krankheiten des nervensystems
DK1794182T3 (en) RELATIONS modulates TRH-EFFECTS AND INHIBITS TRH DECOMPOSITION ENZYME
KR890009974A (ko) 신규 화합물들
WO2002083729A3 (en) Polypeptides derived from amyloid precursor peptide (app) and their uses
ATE360432T1 (de) Peptid zur behandlung von nervenerkrankungen
CY1111301T1 (el) Πολυπεπτιδια που προερχονται απο προδρομο πεπτιδιο αμυλοειδους (αρρ) και οι χρησεις αυτων
TH79013A (th) อะนาลอกบอมเบซินสำหรับการรักษามะเร็ง
TH79013B (th) อะนาลอกบอมเบซินสำหรับการรักษามะเร็ง

Legal Events

Date Code Title Description
8364 No opposition during term of opposition